GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:GSK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Jun 24	BuyUK£32,291	Jonathan Symonds	Individual	2,000	UK£16.15
20 Jun 24	BuyUK£7,196	Wendy Mira Becker	Individual	446	UK£16.14
01 Feb 24	BuyUK£54,972	Jonathan Symonds	Individual	3,500	UK£15.71
01 Feb 24	BuyUK£306,430	Julie Brown	Individual	19,360	UK£15.83
20 Dec 23	BuyUK£28,907	Jonathan Symonds	Individual	2,000	UK£14.45
20 Dec 23	BuyUK£6,929	Urs Rohner	Individual	478	UK£14.50
20 Sep 23	BuyUK£28,994	Jonathan Symonds	Individual	1,900	UK£15.26
20 Sep 23	BuyUK£6,925	Urs Rohner	Individual	453	UK£15.29

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,555,597	0.0381%
Individual Insiders	3,541,414	0.0868%
State or Government	6,700,627	0.164%
Private Companies	46,834,786	1.15%
Employee Share Scheme	73,126,588	1.79%
General Public	457,783,265	11.2%
Institutions	3,489,418,845	85.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 50.5% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.17%	Dodge & Cox	373,909,492	UK£6.1b	-0.53%	2.71%
8.35%	BlackRock, Inc.	340,786,934	UK£5.6b	0.14%	0.12%
4.7%	The Vanguard Group, Inc.	191,784,482	UK£3.1b	0.54%	0.06%
2.23%	State Street Global Advisors, Inc.	91,128,206	UK£1.5b	0.82%	0.07%
2.18%	FMR LLC	88,937,308	UK£1.5b	2.47%	0.12%
2.01%	Legal & General Investment Management Limited	82,006,027	UK£1.3b	-2.33%	0.33%
1.97%	Schroder Investment Management Limited	80,514,711	UK£1.3b	16.7%	1.11%
1.97%	Wellington Management Group LLP	80,177,090	UK£1.3b	13.1%	0.26%
1.94%	Norges Bank Investment Management	79,299,179	UK£1.3b	-7.91%	0.14%
1.79%	GlaxoSmithKline Employee Trust	73,126,588	UK£1.2b	-0.32%	no data
1.51%	UBS Asset Management AG	61,740,928	UK£1.0b	0.27%	0.14%
1.2%	Silchester International Investors LLP	49,126,050	UK£802.5m	-2.54%	3.79%
1.14%	GlaxoSmithKline plc, Shareview Client	46,444,816	UK£758.7m	-0.68%	no data
1.12%	Mondrian Investment Partners Limited	45,730,406	UK£747.0m	0.92%	5.9%
1.11%	HSBC Global Asset Management (UK) Limited	45,281,957	UK£739.7m	0.25%	0.42%
1.03%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	41,852,122	UK£683.7m	-1.31%	23.56%
0.95%	Fisher Asset Management, LLC	38,777,507	UK£633.4m	0.05%	0.36%
0.95%	Aviva Investors Global Services Ltd.	38,724,933	UK£632.6m	-4.45%	1.08%
0.88%	Columbia Management Investment Advisers, LLC	36,029,959	UK£588.5m	-9.38%	0.18%
0.75%	Franklin Resources, Inc.	30,757,266	UK£502.4m	1.98%	0.24%
0.74%	Strategic Advisers LLC	30,316,856	UK£495.2m	13.9%	0.28%
0.71%	PRIMECAP Management Company	29,022,780	UK£474.1m	13.9%	0.45%
0.7%	BNY Asset Management	28,669,192	UK£468.3m	24%	0.12%
0.7%	Royal London Asset Management Ltd.	28,525,811	UK£466.0m	-2.96%	0.78%
0.67%	JP Morgan Asset Management	27,362,990	UK£447.0m	-14%	0.07%